This PROTAC molecule ZL216 is able to promote the formation of a nucleolin–ZL216–VHL ternary complex, resulting in potent nucleolin degradation in breast cancer cells as well as in xenograft models. Here, NUCLEOLIN is linked to breast carcinoma.